Increased Levels of Runt-Related Transcription Factor 2 Are Associated With Poor Survival of Patients With Idiopathic Pulmonary Arterial Hypertension

Runt-related transcription factor 2 (RUNX2) plays a pivotal role in the pathogenesis of pulmonary arterial hypertension (PAH); yet, whether circulating levels of RUNX2 can predict survival of patients with idiopathic PAH (IPAH) is still unclear. The present study aimed to investigate the correlation...

Full description

Bibliographic Details
Main Authors: Xuntao Yuan MD, Zuogang Wang MD, Lan Wang MD, Qinhua Zhao MD, Sugang Gong MD, Yuanyuan Sun MD, Qian Liu MD, Ping Yuan MD
Format: Article
Language:English
Published: SAGE Publishing 2020-07-01
Series:American Journal of Men's Health
Online Access:https://doi.org/10.1177/1557988320945458
_version_ 1818342361070043136
author Xuntao Yuan MD
Zuogang Wang MD
Lan Wang MD
Qinhua Zhao MD
Sugang Gong MD
Yuanyuan Sun MD
Qian Liu MD
Ping Yuan MD
author_facet Xuntao Yuan MD
Zuogang Wang MD
Lan Wang MD
Qinhua Zhao MD
Sugang Gong MD
Yuanyuan Sun MD
Qian Liu MD
Ping Yuan MD
author_sort Xuntao Yuan MD
collection DOAJ
description Runt-related transcription factor 2 (RUNX2) plays a pivotal role in the pathogenesis of pulmonary arterial hypertension (PAH); yet, whether circulating levels of RUNX2 can predict survival of patients with idiopathic PAH (IPAH) is still unclear. The present study aimed to investigate the correlation between circulating levels of RUNX2 and survival of patients with IPAH. Blood samples were collected from 46 incident patients with IPAH and 30 healthy controls in Shanghai Pulmonary Hospital. Levels of RUNX2 were measured using ELISA. Linear regression and cox proportional hazards analysis were performed to assess the prognostic value of RUNX2 levels in predicting survival using the Kaplan–Meier method. Nonsurvivors had significantly shorter 6MWD, higher levels of NT-proBNP, increased mRAP, mPAP, mPAWP, PVR, and decreased CO as well as CI, compared with survivors ( p < .05). Plasma levels of RUNX2 were significantly higher in nonsurvival and survival patients with IPAH compared with controls ( p ≤ .001), and higher in nonsurvivors than in survivors ( p = .001). RUNX2 levels served as an independent predictor of survival in these patients ( p < .001). RUNX2 levels ≥41.5 ng/ml had a sensitivity of 80.0% and a specificity of 74.2% by ROC analysis. Patients with a RUNX2 level <41.5 ng/ml and/or mRAP <3.5 mmHg had a significantly better prognosis than those with a higher RUNX2 level in all subjects as well as in male or female patients ( p < .05). The level of circulating RUNX2 is an independent predictor for survival and it is correlated with the clinical severity of IPAH.
first_indexed 2024-12-13T16:13:28Z
format Article
id doaj.art-096b34ca2ccd41ec8f0f8d14ef2ceb52
institution Directory Open Access Journal
issn 1557-9891
language English
last_indexed 2024-12-13T16:13:28Z
publishDate 2020-07-01
publisher SAGE Publishing
record_format Article
series American Journal of Men's Health
spelling doaj.art-096b34ca2ccd41ec8f0f8d14ef2ceb522022-12-21T23:38:53ZengSAGE PublishingAmerican Journal of Men's Health1557-98912020-07-011410.1177/1557988320945458Increased Levels of Runt-Related Transcription Factor 2 Are Associated With Poor Survival of Patients With Idiopathic Pulmonary Arterial HypertensionXuntao Yuan MD0Zuogang Wang MD1Lan Wang MD2Qinhua Zhao MD3Sugang Gong MD4Yuanyuan Sun MD5Qian Liu MD6Ping Yuan MD7Department of Gastroenterology, Weifang Traditional Chinese Hospital, Shandong, ChinaDepartment of Cardiosurgery, Weifang Traditional Chinese Hospital, Shandong, ChinaDepartment of Cardio-Pulmonary Circulation, School of Medicine, Shanghai Pulmonary Hospital, Tongji University, Shanghai, ChinaDepartment of Cardio-Pulmonary Circulation, School of Medicine, Shanghai Pulmonary Hospital, Tongji University, Shanghai, ChinaDepartment of Cardio-Pulmonary Circulation, School of Medicine, Shanghai Pulmonary Hospital, Tongji University, Shanghai, ChinaDepartment of Cardio-Pulmonary Circulation, School of Medicine, Shanghai Pulmonary Hospital, Tongji University, Shanghai, ChinaDepartment of Respiratory Medicine, School of Medicine, Xinhua Hospital, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Cardio-Pulmonary Circulation, School of Medicine, Shanghai Pulmonary Hospital, Tongji University, Shanghai, ChinaRunt-related transcription factor 2 (RUNX2) plays a pivotal role in the pathogenesis of pulmonary arterial hypertension (PAH); yet, whether circulating levels of RUNX2 can predict survival of patients with idiopathic PAH (IPAH) is still unclear. The present study aimed to investigate the correlation between circulating levels of RUNX2 and survival of patients with IPAH. Blood samples were collected from 46 incident patients with IPAH and 30 healthy controls in Shanghai Pulmonary Hospital. Levels of RUNX2 were measured using ELISA. Linear regression and cox proportional hazards analysis were performed to assess the prognostic value of RUNX2 levels in predicting survival using the Kaplan–Meier method. Nonsurvivors had significantly shorter 6MWD, higher levels of NT-proBNP, increased mRAP, mPAP, mPAWP, PVR, and decreased CO as well as CI, compared with survivors ( p < .05). Plasma levels of RUNX2 were significantly higher in nonsurvival and survival patients with IPAH compared with controls ( p ≤ .001), and higher in nonsurvivors than in survivors ( p = .001). RUNX2 levels served as an independent predictor of survival in these patients ( p < .001). RUNX2 levels ≥41.5 ng/ml had a sensitivity of 80.0% and a specificity of 74.2% by ROC analysis. Patients with a RUNX2 level <41.5 ng/ml and/or mRAP <3.5 mmHg had a significantly better prognosis than those with a higher RUNX2 level in all subjects as well as in male or female patients ( p < .05). The level of circulating RUNX2 is an independent predictor for survival and it is correlated with the clinical severity of IPAH.https://doi.org/10.1177/1557988320945458
spellingShingle Xuntao Yuan MD
Zuogang Wang MD
Lan Wang MD
Qinhua Zhao MD
Sugang Gong MD
Yuanyuan Sun MD
Qian Liu MD
Ping Yuan MD
Increased Levels of Runt-Related Transcription Factor 2 Are Associated With Poor Survival of Patients With Idiopathic Pulmonary Arterial Hypertension
American Journal of Men's Health
title Increased Levels of Runt-Related Transcription Factor 2 Are Associated With Poor Survival of Patients With Idiopathic Pulmonary Arterial Hypertension
title_full Increased Levels of Runt-Related Transcription Factor 2 Are Associated With Poor Survival of Patients With Idiopathic Pulmonary Arterial Hypertension
title_fullStr Increased Levels of Runt-Related Transcription Factor 2 Are Associated With Poor Survival of Patients With Idiopathic Pulmonary Arterial Hypertension
title_full_unstemmed Increased Levels of Runt-Related Transcription Factor 2 Are Associated With Poor Survival of Patients With Idiopathic Pulmonary Arterial Hypertension
title_short Increased Levels of Runt-Related Transcription Factor 2 Are Associated With Poor Survival of Patients With Idiopathic Pulmonary Arterial Hypertension
title_sort increased levels of runt related transcription factor 2 are associated with poor survival of patients with idiopathic pulmonary arterial hypertension
url https://doi.org/10.1177/1557988320945458
work_keys_str_mv AT xuntaoyuanmd increasedlevelsofruntrelatedtranscriptionfactor2areassociatedwithpoorsurvivalofpatientswithidiopathicpulmonaryarterialhypertension
AT zuogangwangmd increasedlevelsofruntrelatedtranscriptionfactor2areassociatedwithpoorsurvivalofpatientswithidiopathicpulmonaryarterialhypertension
AT lanwangmd increasedlevelsofruntrelatedtranscriptionfactor2areassociatedwithpoorsurvivalofpatientswithidiopathicpulmonaryarterialhypertension
AT qinhuazhaomd increasedlevelsofruntrelatedtranscriptionfactor2areassociatedwithpoorsurvivalofpatientswithidiopathicpulmonaryarterialhypertension
AT suganggongmd increasedlevelsofruntrelatedtranscriptionfactor2areassociatedwithpoorsurvivalofpatientswithidiopathicpulmonaryarterialhypertension
AT yuanyuansunmd increasedlevelsofruntrelatedtranscriptionfactor2areassociatedwithpoorsurvivalofpatientswithidiopathicpulmonaryarterialhypertension
AT qianliumd increasedlevelsofruntrelatedtranscriptionfactor2areassociatedwithpoorsurvivalofpatientswithidiopathicpulmonaryarterialhypertension
AT pingyuanmd increasedlevelsofruntrelatedtranscriptionfactor2areassociatedwithpoorsurvivalofpatientswithidiopathicpulmonaryarterialhypertension